Where Technology meets Opportunity in Science and Engineering
Power At your Finger Tips
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 988 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

    Regeneron Pharmaceuticals Inc. (REGN) Receives "Buy" Rating from Leerink Swann - The Cerbat Gem

      Regeneron Pharmaceuticals logo Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)'s stock had its "buy? rating reissued by stock analysts at Leerink Swann in a research note issued on Wednesday. Th Save |  Share  Email 21st Sep 2016 

    SanBio Begins Clinical Trial of Regenerative Cell Medicine for Patients with Traumatic Brain Injury in Japan - Yahoo Finance

      SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, announced today that it has begun a Phase 2 clinical trial of regenerative cell medicin Save |  Share  Email 21st Sep 2016 

    Moderna to spend $110m on mRNA therapeutics manufacturing plant - In-PharmaTechnologist.com

      In-PharmaTechnologist.com Moderna Therapeutics has announced plans for a $110m (?98m) API manufacturing facility for its pipeline of mRNA therapeutics. The facility - which will be built at a site in Norwood, M Save |  Share  Email 21st Sep 2016 

    You Can't Ignore the Biotech Breakout - Daily Reckoning

      Daily Reckoning Sarepta's new drug approval has helped trigger an important breakout in biotech stocks. The SPDR S&P Biotech Index (NYSE:XBI) is jumping above critical levels and approaching its January highs. Keep in mind the sector wa Save |  Share  Email 21st Sep 2016 

    UK likely to remain leader in cell and gene therapies post-Brexit, CGT Catapult - In-PharmaTechnologist.com

      Brexit will not stifle interest in the UK's cell and gene therapy space, says the CGT Catapult which has reported a tenfold growth in investment since 2012 to £400m ($520m). Like Save |  Share  Email 21st Sep 2016 

    Zombie biotech Eleven Bio seeks resurrection with merger deal - FierceBiotech

      FierceBiotech Eleven Bio ($EBIO) is looking to come back to life after being on life support for much of 2016 with a merger deal combining it with private Canadian company Viventia, which will take over at the top of the biote Save |  Share  Email 21st Sep 2016 

    Admera Health Expands its Next Generations Sequencing Based Pharmacogenomics Test with Update to PGxOne ... - EconoTimes

      SOUTH PLAINFIELD, N.J., Sept. 21, 2016 -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) today announced that its PGxOne? Plus pharmacogenomics Save |  Share  Email 21st Sep 2016 

    Non-TNF-targeted biologic vs. a second anti-TNF drug to treat RA - Pharmacy Today, American Pharmacists Association, pharmacist.com

      A recent study out of France compared the efficacy of a non-tumor necrosis factor (TNF)-targeted biologic with a second anti-TNF drug for rheumatoid arthritis (RA) patient Save |  Share  Email 21st Sep 2016 

    Depression in Early Pregnancy Tied to Diabetes - PsychCentral.com (blog)

      PsychCentral.com (blog) Depression and gestational diabetes share a link that appears to run both ways, according to a new study by researchers at the National Institutes of Health (NIH). The findings, published in the journal Diab Save |  Share  Email 21st Sep 2016 

    Mylan Pharmaceuticals CEO defends Epipen costs - 41 NBC News

      41 NBC News The head of Mylan Pharmaceuticals, the company that makes and sells the Epipen, will be on Capitol Hill today. CEO Heather Bresch will say it's not true the company makes big profits of off its lifesaving allergy treatment. Bre Save |  Share  Email 21st Sep 2016 

    3 Stocks to Watch Wednesday: KB Home (KBH), Ariad Pharmaceuticals, Inc. and Microsoft Corporation (MSFT) - Investorplace.com

      Several companies made a little noise after the bell on Tuesday, including KB Home (NYSE:KBH) and Microsoft Corporation (NASDAQ:MSFT). Meanwhile, Ariad Pharmaceuticals, Inc. (NAS Save |  Share  Email 21st Sep 2016 

    Progressive Regenerative Medicine: Celprogen Creates 3D Printed Heart with Human Cardiac Stem Cells - 3DPrint.com

      3DPrint.com Headquartered in Torrance, California, Celprogen is known for their portfolio of therapeutic products, along with research tools like genetic engineering technologies, Save |  Share  Email 21st Sep 2016 

    Bayer, Evotec join hands to develop new treatments for kidney diseases - Pharmaceutical Business Review

      Bayer and German firm Evotec have partnered to develop to new treatments for kidney diseases. Under the five-year, multi-target research partnership, the companies will develop several cli Save |  Share  Email 21st Sep 2016 

    Takeda's Biotech M&A Menu Is Long, Complex - Bloomberg

      Bloomberg Add another entrant to the very crowded biotech M&A market. Takeda, Japan's largest pharma firm, is willing to spend up to $20 billion on acquisitions overseas, the Financial Times reported last week. Its CEO later confirme Save |  Share  Email 21st Sep 2016 

    MYnd Analytics Letter to Shareholders Other OTC:CNSO - GlobeNewswire (press release)

      GlobeNewswire (press release) We appreciate your continued support. We have produced disruptive results for one of the most challenging problems in medicine: reducing trial and error ...MYnd Analytics Letter to Sha Save |  Share  Email 21st Sep 2016 

    Global Regenerative Medicine Market is expected treach $30237 million by 2022 at a CAGR of 33.1% during 2016-2022 - QWTJ LIVE One Stop

      QWTJ LIVE One Stop Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market. Save |  Share  Email 21st Sep 2016 

    Aralez Pharmaceuticals Inc. (ARLZ) Director Robert Paul Harris Sells 150000 Shares - The Cerbat Gem

      Aralez Pharmaceuticals logo Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) Director Robert Paul Harris sold 150,000 shares of the stock in a transaction dated Thursday, September 15th. The stock was sold at a Save |  Share  Email 21st Sep 2016 

    Researchers develop way to ID diabetes patient-specific drugs - Medical Xpress

      Medical Xpress An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease. The research by Weill Cornel Save |  Share  Email 21st Sep 2016 

    German Biotech allies with Genentech in battle for Cancer Vaccine - Labiotech.eu (blog)

      Labiotech.eu (blog) Europe's largest private biotech, BioNTech, has partnered up with Genentech to produce individualized mRNA-based cancer therapies. The collaboration aims to apply Genentech's expertise as Save |  Share  Email 21st Sep 2016 

    Air Pollution Is Linked to a Diabetes Marker - New York Times

      New York Times Exposure to air pollution, a new study finds, may increase glucose intolerance, a precursor of diabetes. German researchers found the effect particularly strong in people who are already considered prediabetic becaus Save |  Share  Email 21st Sep 2016 
    Total record(s) 988 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>